The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines.

By Laura J Smith, Magdalena M Bolsinger, David Chau, PhD, Matthew Gegg, PhD and Anthony Schapira, PhD
View Published Dataset

Output Details

Description

The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines (associated with publication 10.1101/2022.06.01.494130).

Identifier (DOI)
10.5281/zenodo.6985167
Tags
  • Activity Assay
  • GBA (Glucocerebrosidase)
  • GCase activity
  • Human
  • In Vitro
  • Western Blot
Team
Team Schapira
Program
Collaborative Research Network
Theme
Neuro-Immune Interactions

Meet the Authors

Related Research

The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines

The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in fibroblasts.

View Article

Lysosomal GCase (glucocerebrosidase) activity assay

Method to measure lysosomal GBA1 enzyme activity using 4-MUG substrate at low pH to minimize non-lysosomal GCase interference. GBA1 activity higher in purified lysosomes than whole cell extract, confirmed by CBE inhibitor abolishing 4-MUG hydrolysis.

View Protocol

Ex Vivo Mouse Brain Slice Whole-Cell Patch-Clamp Electrophysiology

This protocol outlines steps for performing ex vivo slice whole-cell patch-clamp electrophysiology experiments, including voltage clamp and current clamp recordings as well as optogenetic stimulation in the Ding lab.

View Protocol
View More Outputs